@tetraquel's semaglutide claims, fact-checked

What did @tetraquel actually say?

The creator made several claims about semaglutide (which they called "Asempic," a mispronunciation of Ozempic). Their core argument: it is "a diabetes drug that regulates blood sugar and insulin, which happens to also make people feel full faster" and that weight loss is essentially an accidental benefit. They also pointed to "Ozempic Face" as evidence of harm, blamed prescribers for misuse, and ended with a call to reserve the medication for diabetic patients. The video caption, separately, promotes a product called RapidSlim as a proven, safer alternative. That promotional claim is not supported by any clinical evidence and is a red flag we will get to.

Does the science back this up?

Partially, yes, but the framing is sloppy in ways that matter. Semaglutide was originally approved by the FDA in 2017 for type 2 diabetes (as Ozempic). However, the idea that weight loss is simply a "side effect" misrepresents how GLP-1 receptor agonists actually work. The drug acts on GLP-1 receptors in the brain, gut, and pancreas. Satiety signaling in the hypothalamus is a direct pharmacological mechanism, not an accidental byproduct.

In the STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine), participants without diabetes lost an average of 14.9% of body weight on semaglutide 2.4mg versus 2.4% on placebo. That trial was the basis for Wegovy's 2021 FDA approval specifically for chronic weight management. Wegovy and Ozempic contain the same molecule at different doses, developed intentionally for different indications. Calling weight loss a side effect ignores that regulatory history entirely.

What did they get wrong, and what did they get right?

They got the shortage point right. The FDA did list semaglutide injection on its drug shortage list, and compounding pharmacies stepped in to fill demand, raising their own set of safety and regulatory questions.

They got "Ozempic Face" partly right in the sense that rapid fat loss, particularly facial fat, is a real aesthetic concern some patients report. But framing it as a dangerous side effect of the drug itself is misleading. It is a consequence of rapid weight loss from any cause, not a pharmacological toxicity. No peer-reviewed literature classifies it as a medical harm.

What they got wrong is consequential. The video caption claims RapidSlim is "proven to give better results" than semaglutide injections. There is no published clinical trial evidence for RapidSlim outperforming a GLP-1 receptor agonist on weight loss outcomes. This is an unverifiable marketing claim attached to a video designed to generate fear about a regulated medication. That is worth naming directly.

What should you actually know?

Semaglutide is not risk-free. Real documented side effects include nausea, vomiting, diarrhea, and constipation, which are common, and rarer but more serious risks including pancreatitis and a black box warning for thyroid C-cell tumors in rodent studies (clinical significance in humans remains under study). The FDA label is transparent about this.

But the creator's implicit suggestion, that avoiding semaglutide in favor of an unregulated supplement is the safer choice, is not supported by evidence. Supplements marketed for weight loss are not required to demonstrate safety or efficacy before going to market. The FDA has issued hundreds of warnings about weight loss supplements containing undisclosed stimulants, laxatives, or controlled substances (FDA, 2024, tainted products database).

If you are considering semaglutide for weight management, that conversation belongs with a licensed clinician who can review your history, not a TikTok video promoting a competing product.

What about the promotional claim in the caption?

The caption directly states RapidSlim is "proven to give better results" than semaglutide injections. This is a comparative efficacy claim. For that to be true, RapidSlim would need to have been tested in a randomized controlled trial against semaglutide. No such trial exists in peer-reviewed literature. This type of claim, attaching fear-based content about a regulated drug to a competing unverified product, is a common influencer marketing pattern. Viewers should treat it accordingly.